Health and Fitness Health and Fitness
Mon, October 10, 2011
[ Mon, Oct 10th 2011 ] - Market Wire
Health Net Receives Full URAC Accreditation for Disease Management
[ Mon, Oct 10th 2011 ] - Market Wire
Innovative Pipelines From Avanir and Cyclacel Pharmaceuticals Gain Momentum
[ Mon, Oct 10th 2011 ] - Market Wire
Equity Research on Humana Inc. and WellPoint Inc. - Obamacare Helping Several Health Insurers
[ Mon, Oct 10th 2011 ] - Market Wire
St. Jude Medical Advances Its Remote Patient Monitoring System with Mobile Notifications
[ Mon, Oct 10th 2011 ] - Market Wire
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn®
[ Mon, Oct 10th 2011 ] - Market Wire
Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results
[ Mon, Oct 10th 2011 ] - Market Wire
Medtronic Announces Results from TTOP-AF Trial De .. of Its Phased RF Ablation System in Treating Per
[ Mon, Oct 10th 2011 ] - Market Wire
PAREXEL and National University of Singapore Esta .. Meet Increasing Demand in Asia for Clinical Rese
[ Mon, Oct 10th 2011 ] - Market Wire
Inovio Pharmaceuticals and VGX International to A .. C and Hepatitis B Synthetic Vaccines into Clinica
Sun, October 9, 2011
[ Sun, Oct 09th 2011 ] - Market Wire
Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
[ Sun, Oct 09th 2011 ] - Market Wire
Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
Sat, October 8, 2011
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. Daily Therapy for Patients with Type 2 Diabetes W
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. 9;; a Once-Daily Therapy for Patients with
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;; a Once-Daily Therapy for Patients w
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. e-Daily Therapy for Patients with Type 2 Diabetes
[ Sat, Oct 08th 2011 ] - Market Wire
KCI Announces Proposed Offering of Senior Notes
[ Sat, Oct 08th 2011 ] - Market Wire
Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
[ Sat, Oct 08th 2011 ] - Market Wire
West Increases Quarterly Dividend to $0.18
[ Sat, Oct 08th 2011 ] - Market Wire
Amerigroup Enhances Maternal Outreach Efforts
[ Sat, Oct 08th 2011 ] - Market Wire
IBM Launches University Competition to Combat Growth of Non-Communicable Diseases
Fri, October 7, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Continues Inve .. ation of Pharmaceutical Product Development, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Advitech and Natunola Announce Completion of Merg .. Private Placement and Change of Name to Botaneco
[ Fri, Oct 07th 2011 ] - Market Wire
MEDNAX 2011 Third Quarter Conference Call/Webcast Scheduled for Tuesday, November 1, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Vertex Announces the Date of its Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 07th 2011 ] - Market Wire
Cardiovascular Systems Announces Preliminary First-Quarter Financial Results
[ Fri, Oct 07th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n MELA Sciences, Inc. and SIGA Technologies, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Expert's Economic Outlook, Global - Equity Resear .. harmaceutical Companies, Inc. and Targacept, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Adherex Reports Meeting With FDA's Pediatric Subc .. gs Advisory Committee on the Development of Sodiu
[ Fri, Oct 07th 2011 ] - Market Wire
Senetek Announces Work Plans at Iron Creek Project
Thu, October 6, 2011
[ Thu, Oct 06th 2011 ] - Market Wire
Hansen Medical Announces Settlement of SEC Investigation
[ Thu, Oct 06th 2011 ] - Market Wire
Patient Home Monitoring Announces Unaudited Reven .. for September 2011, and Growth Figures for Q4 20
[ Thu, Oct 06th 2011 ] - Market Wire
Equity Research on Gilead Sciences Inc. and Human .. . - Regulatory Approval Key for Biotech Companies
[ Thu, Oct 06th 2011 ] - Market Wire
Peregrine Completes Patient Enrollment in Second- .. er Trial;; Data to Be Unblinded in First H
[ Thu, Oct 06th 2011 ] - Market Wire
Trimel Provides Update on Female Sexual Dysfunction "Anorgasmia" Clinical Program
[ Thu, Oct 06th 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference
[ Thu, Oct 06th 2011 ] - Market Wire
Alexza and Grupo Ferrer Establish Partnership for .. uvea" (Staccato® Loxapine) in Europe and Latin A
[ Thu, Oct 06th 2011 ] - Market Wire
Greystone Logistics Announces Record Sales in 4th Quarter
[ Thu, Oct 06th 2011 ] - Market Wire
The Ensign Group Acquires La Jolla Skilled Nursing Facility
Wed, October 5, 2011
[ Wed, Oct 05th 2011 ] - Market Wire
Basilea receives request for extraordinary shareh .. lect additional members to the board of directors
[ Wed, Oct 05th 2011 ] - Market Wire
Waters Empowers Advantar Laboratories for Sustained Growth
[ Wed, Oct 05th 2011 ] - Market Wire
Investigational Oral Multiple Sclerosis Therapy T .. ignificantly Reduced Relapse Rate, Disability Pro
[ Wed, Oct 05th 2011 ] - Market Wire
MURRAY FRANK LLP Announces Investigation of Pharmaceutical Product Development, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of DaVita, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Voclosporin study published in the American Journal of Transplantation
[ Wed, Oct 05th 2011 ] - Market Wire
OncoSec Releases Devices for Use in Clinical Trials
[ Wed, Oct 05th 2011 ] - Market Wire
Inovio Pharmaceuticals' Synthetic Vaccine for Can .. ost Promising Research at Global Vaccine Congress
Tue, October 4, 2011
[ Tue, Oct 04th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Announces Inve .. ation of Pharmaceutical Product Development, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates DaVita, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
POZEN Provides Patent Litigation and Financial Guidance Update
[ Tue, Oct 04th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Neurocrine Biosciences Receives Second Milestone .. $20 Million Under Abbott Collaboration Agreement
[ Tue, Oct 04th 2011 ] - Market Wire
Investigation of Pharmaceutical Product Developme .. oldfarb Branham Law Firm LLP for Potential Shareh
[ Tue, Oct 04th 2011 ] - Market Wire
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
[ Tue, Oct 04th 2011 ] - Market Wire
Initial Data from Bio-Path Holdingsa? Phase I Cli .. entation at American Society of Hematology Annual
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Inve .. tion of Pharmaceuticals Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results
[ Mon, Oct 03rd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces I .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Pharmaceutical Product Development
[ Mon, Oct 03rd 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Annou .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Medwell Capital to Adopt IFRS
[ Mon, Oct 03rd 2011 ] - Market Wire
IMRIS Announces Retirement of Chief Operating Officer
[ Mon, Oct 03rd 2011 ] - Market Wire
Allegiance Completes Private Placement Of 229,166 Common At $0.48 Per Share
Sun, October 2, 2011
[ Sun, Oct 02nd 2011 ] - Market Wire
HeartWare Reports Additional Clinical Data From B .. nued Access Patients at the 25th European Associa
Sat, October 1, 2011
[ Sat, Oct 01st 2011 ] - Market Wire
HealthSpring Unveils 2012 Medicare Advantage Plans
Fri, September 30, 2011
[ Fri, Sep 30th 2011 ] - Market Wire
AxoGen, Inc. Announces Completion of Merger, Name Change and Executive Team Changes
[ Fri, Sep 30th 2011 ] - Market Wire
Health Management Associates, Inc. Completes the .. alth Partners from Catholic Health Partners, Inc.
[ Fri, Sep 30th 2011 ] - Market Wire
Merck Announces New Data Analyses for VICTRELISa" .. ed at The American Association for the Study of L
[ Fri, Sep 30th 2011 ] - Market Wire
Vertex to Present New Data from Hepatitis C Development Program at AASLD Annual Meeting
[ Fri, Sep 30th 2011 ] - Market Wire
Reminding Seniors to Be Mindful of Medications
[ Fri, Sep 30th 2011 ] - Market Wire
Merck to Hold Third-Quarter 2011 Sales and Earnings Conference Call on October 28
[ Fri, Sep 30th 2011 ] - Market Wire
A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[ Fri, Sep 30th 2011 ] - Market Wire
ShangPharma to Attend Upcoming Investor Conferences in October
[ Fri, Sep 30th 2011 ] - Market Wire
Concord Medical Services Announces Share Repurchase Program
Thu, September 29, 2011
[ Thu, Sep 29th 2011 ] - Market Wire
Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial
[ Thu, Sep 29th 2011 ] - Market Wire
Biogen Idec bevordert Tony Kingsley tot hoofd van Global Commercial Operations
[ Thu, Sep 29th 2011 ] - Market Wire
Galectin Therapeutics Posts New Corporate Presentation Video to its Website
[ Thu, Sep 29th 2011 ] - Market Wire
SANUWAVE Appoints Private Equity Veteran Barbara M. Henagan to Its Board of Directors
[ Thu, Sep 29th 2011 ] - Market Wire
The National Association Of Boards Of Pharmacy An .. Patients About The Flood Of Counterfeit Medicines
[ Thu, Sep 29th 2011 ] - Market Wire
Federal Fire Department in Pearl Harbor Uses ZOLL .. ave 37-Year-Old Seaman from Sudden Cardiac Arrest
[ Thu, Sep 29th 2011 ] - Market Wire
NanoViricides Inc Files For Extension of Form 10-K Annual Report Submission Date
[ Thu, Sep 29th 2011 ] - Market Wire
Illumina Introduces Low-Cost Bovine BeadChip for Genotyping of Dairy Cattle
[ Thu, Sep 29th 2011 ] - Market Wire
Chronic Conditions Cost UK Economy More Than 20 Billion Pounds a Year
Wed, September 28, 2011
[ Wed, Sep 28th 2011 ] - Market Wire
Five Days Remain before Deadline in Class-action Lawsuit against Dendreon, Says Hagens Berman
[ Wed, Sep 28th 2011 ] - Market Wire
HeartWare Announces Presentation of Clinical Data .. tion for Cardio-Thoracic Surgery (EACTS) Annual M
[ Wed, Sep 28th 2011 ] - Market Wire
BioDelivery Sciences Announces Results from Phase .. cacy Study for BEMA Buprenorphine in Chronic Pain
[ Wed, Sep 28th 2011 ] - Market Wire
Experts to Provide Successful Strategies for Glob .. ent and Commercialization at PAREXEL Tokyo Semina
[ Wed, Sep 28th 2011 ] - Market Wire
Boston Scientific Announces Favorable Appellate C .. ming Non-Infringement of Johnson & Johnson Patent
[ Wed, Sep 28th 2011 ] - Market Wire
Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals
[ Wed, Sep 28th 2011 ] - Market Wire
IntegraMed Promotes Tim Sheehan to SVP and CFO
[ Wed, Sep 28th 2011 ] - Market Wire
ImmunoCellular Therapeuticsa? ICT-107 Recognized .. hovera?s Top 10 Most Licensable Oncology Products
[ Wed, Sep 28th 2011 ] - Market Wire
Amyris e Michelin Anunciam Colaborao para Desenvolver e Comercializar Isopreno de Fontes Renovveis
Tue, September 27, 2011
[ Tue, Sep 27th 2011 ] - Market Wire
Gallup und Healthways verffentlichen erste Ergebn .. s Well-Being (Wohlbefindens)-Index fr Deutschland
[ Tue, Sep 27th 2011 ] - Market Wire
HCA Announces Proposed Public Offering of $500 Million Senior Notes
[ Tue, Sep 27th 2011 ] - Market Wire
Catasys Launches Its Integrated Substance Dependence Program in Massachusetts
[ Tue, Sep 27th 2011 ] - Market Wire
Merck Names Cuong Viet Do as Chief Strategy Officer
[ Tue, Sep 27th 2011 ] - Market Wire
POZEN Announces October 4, 2011 Mid-Quarter Update and Financial Guidance Webcast
[ Tue, Sep 27th 2011 ] - Market Wire
BioLineRx to Present Data from the Successfully C .. L-1020 at European Conference on Schizophrenia Re
[ Tue, Sep 27th 2011 ] - Market Wire
Molina Healthcare Names Michael Steele as Senior Vice President of Dual Eligible Strategies
[ Tue, Sep 27th 2011 ] - Market Wire
Alexion recibe opinin positiva del CHMP para Soli .. s con sndrome ur©mico hemoltico atpico (aHUS) en
[ Tue, Sep 27th 2011 ] - Market Wire
Evidence of AT13387 Activity in Gastrointestinal Stromal Tumor Models Presented at ECCO
Mon, September 26, 2011
[ Mon, Sep 26th 2011 ] - Market Wire
Guidance For Cannabis Science Brand Products To B .. lorado Based On Accumulating Anecdotal Reports Of
[ Mon, Sep 26th 2011 ] - Market Wire
Health Net Sponsors 2011 Congressional Medal of Honor Convention and Star-Studded Tribute Concert
[ Mon, Sep 26th 2011 ] - Market Wire
Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device
[ Mon, Sep 26th 2011 ] - Market Wire
Alnylam Initiates Phase I Clinical Study of ALN-P .. ting PCSK9 for the Treatment of Severe Hyperchole
[ Mon, Sep 26th 2011 ] - Market Wire
Synta Announces Presentation of Results of Ganete .. udy in Combination with Docetaxel in Solid Tumors
[ Mon, Sep 26th 2011 ] - Market Wire
iCo Therapeutics and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema
[ Mon, Sep 26th 2011 ] - Market Wire
ARIAD Announces Long-Term Follow Up of Patients w .. stant CML Treated with Ponatinib in Phase 1 Trial
[ Mon, Sep 26th 2011 ] - Market Wire
Millennium y Seattle Genetics presentan datos cln .. uximab Vedotin) en pacientes peditricos en reunin
[ Mon, Sep 26th 2011 ] - Market Wire
National Hospice and Palliative Care Expert Joins Amedisys
Sat, September 24, 2011
[ Sat, Sep 24th 2011 ] - Market Wire
FDA lsst Soliris® (Eculizumab) zur Behandlung al .. atypischem hmolytisch-urmischem Syndrom (aHUS) zu
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium en Seattle Genetics presenteren klinis .. brentuximab vedotin) bij pediatrische patinten op
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, la?oc .. de la?EMCC, des donn©es cliniques concernant la?
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent la?occ .. e la?EMCC des donn©es cliniques concernant la?ut
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, .. occasion de la r©union annuelle de la?EMCC,&#
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium and Seattle Genetics Present Clinical .. mab Vedotin) in Pediatric Patients at EMCC Annual
Fri, September 23, 2011
[ Fri, Sep 23rd 2011 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene: reglementaire update inzake REVLIMID
[ Fri, Sep 23rd 2011 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Investigation of American Medical Alert Corp.
[ Fri, Sep 23rd 2011 ] - Market Wire
European CHMP Adopts Positive Opinion for Evipler .. Tablet Regimen for the Treatment of HIV Infection
[ Fri, Sep 23rd 2011 ] - Market Wire
MISE JOUR RGLEMENTAIRE DE CELGENE AU SUJET DE REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene prsentiert aktuelle Informationen zur Marktzulassung von REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
AGGIORNAMENTO REGOLATORIO DI CELGENE CIRCA REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene Regulatory Update on REVLIMID®
Thu, September 22, 2011
[ Thu, Sep 22nd 2011 ] - Market Wire
Enzon Announces Reduction in Force to Align Operations with Research and Development Activities
[ Thu, Sep 22nd 2011 ] - Market Wire
U.S. Physical Therapy to Present at the The Sixth Annual JMP Securities Healthcare Conference
[ Thu, Sep 22nd 2011 ] - Market Wire
Brain Resource Opens U.S. Headquarters in San Francisco
[ Thu, Sep 22nd 2011 ] - Market Wire
PFCD Hill Briefing Demonstrates How Health Indices Promote Prevention and Improve Overall Health
[ Thu, Sep 22nd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Dendreon Corporation
[ Thu, Sep 22nd 2011 ] - Market Wire
dermaPACE Pivotal Phase III Clinical Trial Data i .. r Healing to Be Presented at Plastic Surgery 2011
[ Thu, Sep 22nd 2011 ] - Market Wire
Columbia Laboratories Extends Stockholder Rights .. rve Use of Net Operating Losses under Section 382
[ Thu, Sep 22nd 2011 ] - Market Wire
The Future of Ablation Therapies Conference
Wed, September 21, 2011
[ Wed, Sep 21st 2011 ] - Market Wire
Less Than Two Weeks Remain before Deadline in Cla .. tion Lawsuit against Dendreon, Says Hagens Berman
[ Wed, Sep 21st 2011 ] - Market Wire
Health Net Announces Appearance at Credit Suisse 2nd Annual Small & Mid Cap Conference
[ Wed, Sep 21st 2011 ] - Market Wire
Alnylam to Webcast Presentation at the JMP Securities Healthcare Conference
[ Wed, Sep 21st 2011 ] - Market Wire
ACADIA Pharmaceuticals to Present at the Sixth An .. ities Healthcare Conference on September 28, 2011
[ Wed, Sep 21st 2011 ] - Market Wire
ARIAD Announces Start of Enrollment in Phase 1/2 .. 3, an Investigational Dual Inhibitor of ALK and E
[ Wed, Sep 21st 2011 ] - Market Wire
Celgene Corporation to Present at JMP Securities Healthcare Conference 2011
[ Wed, Sep 21st 2011 ] - Market Wire
Independent Proxy Advisory Firms ISS and Glass Le .. hareholders Vote in Favour of Plan of Arrangement
[ Wed, Sep 21st 2011 ] - Market Wire
Smith & Nephew Introduces New Hysteroscopic Morce .. on Simulator Designed to Enhance Surgeon Training
Tue, September 20, 2011
[ Tue, Sep 20th 2011 ] - Market Wire
Jury Awards Medtronic $101 Million in Patent Suit against NuVasive
[ Tue, Sep 20th 2011 ] - Market Wire
Manny Villafaa Discusses FDA Update for Kips Bay Medical
[ Tue, Sep 20th 2011 ] - Market Wire
St. Jude Medical meldt Europese introductie van kleiner quadripolair pacingsysteem
[ Tue, Sep 20th 2011 ] - Market Wire
??????????????,?52???,2???????????????????ONGLYZAa" (????)???????(HbA1c)??
[ Tue, Sep 20th 2011 ] - Market Wire
Merck Joins Global Fight to Help Save Women's Lives During Pregnancy and Childbirth
[ Tue, Sep 20th 2011 ] - Market Wire
Pfizer Announces Expiration of Subsequent Offerin .. letion of Tender Offer for Shares of Icagen, Inc.
[ Tue, Sep 20th 2011 ] - Market Wire
Centric Health to Acquire Medical Imaging Centres Inc. and Rads 24/7 Teleradiology Consultants
[ Tue, Sep 20th 2011 ] - Market Wire
Covidien to Present at Jefferies 2011 Global Healthcare Conference
Mon, September 19, 2011
[ Mon, Sep 19th 2011 ] - Market Wire
Alere Acquires Additional Shares of Axis-Shield
[ Mon, Sep 19th 2011 ] - Market Wire
NeuroMetrix Reports Product Milestone
[ Mon, Sep 19th 2011 ] - Market Wire
Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer
[ Mon, Sep 19th 2011 ] - Market Wire
FDA Panel to Review AtriCurea?s Synergy Ablation System on October 26
[ Mon, Sep 19th 2011 ] - Market Wire
Inhibitex Commences Dosing of Phase 2 Clinical Tr .. of INX-189 in HCV Infected Genotype 2/3 Patients
[ Mon, Sep 19th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) (saxagliptina) adicionado .. abetes tipo 2 manteve redues nos nveis de acar no
[ Mon, Sep 19th 2011 ] - Market Wire
Extensin de un estudio en fase de investigacin de .. liptina) incorporado a la insulina en adultos con
[ Mon, Sep 19th 2011 ] - Market Wire
Cord Blood America Updates Investors on Laboratory Licensing
Sun, September 18, 2011
[ Sun, Sep 18th 2011 ] - Market Wire
Sangamo BioSciences Announces Presentation of Gro .. a From ZFN Therapeutic for HIV/AIDS at ICAAC 2011
Sat, September 17, 2011
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d'une ©tude exp .. ptine) plus insuline chez les patients adultes at
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d'une ©tude exp .. tine) plus insuline chez les patients adultes att
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d';&# .. 4;;; ONGLYZAa" (saxagliptine) plus insu
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d';&# .. ntale,;;;;; ONGLYZAa" (saxagli
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
Fri, September 16, 2011
[ Fri, Sep 16th 2011 ] - Market Wire
Misonix Schedules Fourth Quarter and Year-End Fis .. nference Call;; September 20, 2011 at 4:30
[ Fri, Sep 16th 2011 ] - Market Wire
NPS Pharmaceuticals Highlights Hypoparathyroidism .. al Meeting of American Society for Bone and Miner
[ Fri, Sep 16th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) toegevoegd aan insuline b .. ype 2 bood duurzame verlaging van het bloedsuiker
[ Fri, Sep 16th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) When Added to Insulin in .. aintained Reductions in Blood Sugar Levels (HbA1c
[ Fri, Sep 16th 2011 ] - Market Wire
BioLineRx to Present at Annual UBS Global Life Sciences Conference in New York on September 21st
[ Fri, Sep 16th 2011 ] - Market Wire
New data for once-daily linagliptin show durable efficacy over two years
[ Fri, Sep 16th 2011 ] - Market Wire
Centene Corporation Elects Orlando Ayala of Microsoft to Board of Directors
[ Fri, Sep 16th 2011 ] - Market Wire
Jazz Pharmaceuticals Announces Presentation at th .. e Sciences Conference in New York on September 20
Thu, September 15, 2011
[ Thu, Sep 15th 2011 ] - Market Wire
Covidien kondigt O&O-centrum in China aan
[ Thu, Sep 15th 2011 ] - Market Wire
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
[ Thu, Sep 15th 2011 ] - Market Wire
Covidien Announces R&D Center in China
[ Thu, Sep 15th 2011 ] - Market Wire
Covidien construye centro de investigacin y desarrollo en China
[ Thu, Sep 15th 2011 ] - Market Wire
BioLineRx Announces European Confirmation of Medi .. for BL-5010, for Non-surgical Removal of Skin Le
[ Thu, Sep 15th 2011 ] - Market Wire
Cubist Antibiotic Programs Featured in 49 Presentations at 51st ICAAC
[ Thu, Sep 15th 2011 ] - Market Wire
Cord Blood America CEO Statement to Shareholders
[ Thu, Sep 15th 2011 ] - Market Wire
ShangPharma Subsidiary and Jiangsu Hengrui Medici .. in Therapeutic Antibody Research and Development
Wed, September 14, 2011
[ Wed, Sep 14th 2011 ] - Market Wire
Vanda Pharmaceuticals to Participate in UBS Global Life Sciences Conference
[ Wed, Sep 14th 2011 ] - Market Wire
Le New England Journal of Medicine publie des don .. MINATE da?INCIVEKMC (T©lapr©vir) sur la?h©pati
[ Wed, Sep 14th 2011 ] - Market Wire
Thirty-Five Health Management Hospitals Named Top .. s on Key Quality Measures by the Joint Commission
[ Wed, Sep 14th 2011 ] - Market Wire
Greatbatch, Inc. to Participate in the UBS Global Life Sciences Conference
[ Wed, Sep 14th 2011 ] - Market Wire
HealthSpring Among Fortunea?s 100 Fastest Growing Companies
[ Wed, Sep 14th 2011 ] - Market Wire
PPD Named to InformationWeek 500 List of U.S. Business Technology Innovators
[ Wed, Sep 14th 2011 ] - Market Wire
Astex Pharmaceuticals to Present at UBS Global Life Sciences Conference on September 21st
[ Wed, Sep 14th 2011 ] - Market Wire
Medtronic Pledges Action in Advance of United Nat .. ns High Level Meeting on Noncommunicable Diseases
Tue, September 13, 2011
[ Tue, Sep 13th 2011 ] - Market Wire
Nordion Inc. Declares Quarterly Dividend
[ Tue, Sep 13th 2011 ] - Market Wire
Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan
[ Tue, Sep 13th 2011 ] - Market Wire
Transcept Pharmaceuticals Announces FDA Response .. l in Support of Intermezzo® New Drug Application
[ Tue, Sep 13th 2011 ] - Market Wire
InterMune Announces Pricing of Concurrent Public .. of Common Stock and $135 Million Principal Amoun
[ Tue, Sep 13th 2011 ] - Market Wire
Merck Statement on GARDASIL®
[ Tue, Sep 13th 2011 ] - Market Wire
Cambridge Heart Expands Distribution into Latin America
[ Tue, Sep 13th 2011 ] - Market Wire
Human Genome Sciences Invites Investors to Listen .. ation at Bank of America Merrill Lynch Conference
[ Tue, Sep 13th 2011 ] - Market Wire
HCA Appoints Dr. Michael Cuffe President and CEO of Physician Services for HCA

Millennium e Seattle Genetics presentano dati clinici su ADCETRISa" (brentuximab vedotin) nei pazienti pediatrici all'&


//health-fitness.news-articles.net/content/2011/ .. vedotin-nei-pazienti-pediatrici-all-apos-59.html
Published in Health and Fitness on Saturday, September 24th 2011 at 5:46 GMT by Market Wire   Print publication without navigation


CAMBRIDGE, Massachusetts e BOTHELL, Washington--([ BUSINESS WIRE ])--[ Millennium: The Takeda Oncology Company ], societ? controllata al 100% da Takeda Pharmaceutical Company Limited (TSE:4502), e Seattle Genetics, Inc. (Nasdaq: SGEN) hanno annunciato in data odierna i dati ottenuti da un'analisi retrospettiva di pazienti pediatrici (12-17 anni) arruolati in quattro sperimentazioni cliniche multicentriche (due di fase I e due di fase II) di ADCETRIS. La diagnosi per tutti i pazienti era di linfoma di Hodgkin recidivante o refrattario (LH)(n=5) o linfoma sistemico anaplastico a grandi cellule (sALCL) (n=4) con fallimento di almeno un precedente regime chemioterapico.

Il testo originale del presente annuncio, redatto nella lingua di partenza, ? la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit? del lettore e devono rinviare al testo in lingua originale, che ? l'unico giuridicamente valido.


Publication Contributing Sources